Meeting
2023 ASCO Breakthrough
Dosimetric feasibility of dose-painting radiotherapy for targeting hypoxia in prostate cancer on a novel ring gantry radiotherapy system.
Authors
Karine Feghali
RefleXion Medical, Hayward, CA
Karine Feghali , Tanguy Perennec , Oluwaseyi M. Oderinde , Arjun Maniyedath , Alexandra Moignier , Caroline Rousseau , Ludovic Ferrer , Gregory Delpon , Matthieu Hatt , Yves Seroux , Melanie Doré , Stephane Supiot
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Breast Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Hematologic Malignancies,Thoracic Cancers,Other Malignancies or Topics
Sub Track
Local Disease
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 73)
DOI
10.1200/GO.2023.9.Supplement_1.73
Abstract #
73
Poster Bd #
D9
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Clinical and patient-reported outcomes of fully adaptive MR-guided stereotactic radiotherapy to prostate: Real-world experience from the UK.
First Author: Prantik Das
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter
Poster
2022 ASCO Genitourinary Cancers Symposium
Bladder volume variation in hypofractionated prostate radiotherapy.
First Author: Ronan Joyce
Poster
2020 Genitourinary Cancers Symposium
A prospective comparison of MRI-planned versus CT-planned radiotherapy for prostate cancer.
First Author: Daniel R Schmidt